Skip to main content
PFE
NYSE Life Sciences

Pfizer's Lorbrena Shows 55% 7-Year PFS in NSCLC; EU Clears Pediatric COVID Vaccine Dose

Tom Rudovsky · Reported by Wiseek News
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$26.14
Mkt Cap
$149.211B
52W Low
$23.06
52W High
$28.745
52W Position info
13% above low
Off High info
9.1% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

PFE is trading near its 52-week low of $23.06 (13% above the low).

Summary

Pfizer announced strong 7-year progression-free survival data for its advanced NSCLC drug, Lorbrena, with 55% of patients remaining progression-free and median PFS not yet reached. Concurrently, the EU granted clearance for a 10 µg pediatric dose of its COVID vaccine for children aged 6 months to 11 years. The Lorbrena data significantly reinforces the drug's long-term efficacy and strengthens Pfizer's oncology pipeline. The EU approval expands the market for its COVID vaccine. These positive product developments follow the company's strong Q1 earnings and share repurchase program announced earlier in May.

At the time of this announcement, PFE was trading at $26.14 on NYSE in the Life Sciences sector, with a market capitalization of approximately $149.2B. The 52-week trading range was $23.06 to $28.75. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

PFE - Latest Insights

PFE
Nov 16, 2026, 6:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $29.12
Real-time Price: $28.89 info
Change: -$0.230 (-0.79%) info
Market Cap: $164.498B info
PFE
Nov 13, 2026, 3:19 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $28.85
Real-time Price: $28.89 info
Change: +$0.0375 (+0.13%) info
Market Cap: $164.498B info
PFE
Nov 11, 2026, 4:30 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $29.45
Real-time Price: $28.89 info
Change: -$0.560 (-2%) info
Market Cap: $164.498B info
PFE
Nov 03, 2026, 8:19 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $30.66
Real-time Price: $28.89 info
Change: -$1.77 (-6%) info
Market Cap: $164.498B info
PFE
Nov 03, 2026, 8:07 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $30.62
Real-time Price: $28.89 info
Change: -$1.73 (-6%) info
Market Cap: $164.498B info